Stock Events

Stock Events

Clearmind Medicine 

€2.26
25
+€0+0% Tuesday 08:15

Statistics

Day High
2.26
Day Low
2.26
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31JulExpected
Q2 2016
Q3 2016
Q4 2016
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-1.91
-1.28
-0.64
-0
Expected EPS
N/A
Actual EPS
-1.192

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.86MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CWY.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
COMPASS Pathways is focused on psilocybin therapy for mental health conditions, competing in the psychedelic medicine sector alongside Clearmind Medicine.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences is a biotech company developing treatments for mental health disorders, including psychedelic and non-psychedelic compounds, making it a competitor in the broader mental health treatment market.
GH Research
GHRS
Mkt Cap888.26M
GH Research is developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment market for mental health, similar to Clearmind's objectives.
Cybin Inc
CYBN
Mkt Cap200.49M
Cybin Inc. is working on psychedelic therapeutics for psychiatric and neurological conditions, directly competing with Clearmind Medicine in the psychedelic medicine space.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in the development of psychedelic therapies and wellness services, competing in the same sector as Clearmind Medicine.
MiniMed Group
MMED
Mkt Cap0
MindMedicine (MindMed) Inc. is another key player in the psychedelic medicine space, focusing on developing treatments for mental illness and addiction, directly competing with Clearmind Medicine.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics is exploring the use of psychedelics in treatments, including psilocybin for substance abuse, positioning it as a competitor in the psychedelic therapy market.

About

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Show more...
CEO
ISIN
CA1850535016
WKN
000A41YK5

Listings

F
DE
CWY.F
XNAS
US
CMND
BOATS
BOATS
CMND.BOATS

0 Comments

Share your thoughts

FAQ

What is Clearmind Medicine stock price today?▼
The current price of CWY.F is €2.26 EUR — it has increased by +0% in the past 24 hours. Watch Clearmind Medicine stock price performance more closely on the chart.
What is Clearmind Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clearmind Medicine stocks are traded under the ticker CWY.F.
What is Clearmind Medicine revenue for the last year?▼
Clearmind Medicine revenue for the last year amounts to 0 EUR.
What is Clearmind Medicine net income for the last year?▼
CWY.F net income for the last year is -4.86M EUR.
When did Clearmind Medicine complete a stock split?▼
The last stock split for Clearmind Medicine was on December 15, 2025 with a ratio of 1:40.